VF
AQST icon

Virtu Financial’s Aquestive Therapeutics AQST Stock Holding History

Virtu Financial’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Buy
+69,576
New +$293K 0.01% 749
2025
Q4 		– Sell
-118,329
Closed -$661K – 1630
2025
Q3 		$661K Buy
+118,329
New +$512K 0.04% 456
2025
Q2 		– Sell
-20,075
Closed -$58K – 1428
2025
Q1 		$58K Buy
+20,075
New +$60.8K ﹤0.01% 991
2024
Q4 		– Sell
-22,986
Closed -$114K – 1522
2024
Q3 		$114K Sell
22,986
-14,915
-39% -$58K 0.01% 884
2024
Q2 		$99K Sell
37,901
-64,935
-63% -$217K 0.01% 829
2024
Q1 		$438K Buy
102,836
+70,666
+220% +$235K 0.03% 459
2023
Q4 		$65K Buy
+32,170
New +$56.8K 0.01% 1128
2023
Q2 		– Sell
-12,884
Closed -$15K – 1489
2023
Q1 		$15K Buy
+12,884
New +$11.2K ﹤0.01% 1298
2022
Q3 		– Sell
-106,408
Closed -$68K – 1702
2022
Q2 		$68K Buy
106,408
+95,693
+893% +$127K 0.01% 1034
2022
Q1 		$28K Sell
10,715
-68,423
-86% -$200K ﹤0.01% 1248
2021
Q4 		$308K Buy
+79,138
New +$397K 0.03% 598
2021
Q3 		– Sell
-18,521
Closed -$74K – 1475
2021
Q2 		$74K Buy
+18,521
New +$74K 0.01% 1265
2021
Q1 		– Sell
-59,050
Closed -$316K – 1574
2020
Q4 		$316K Sell
59,050
-58,156
-50% -$349K 0.03% 618
2020
Q3 		$569K Buy
117,206
+106,273
+972% +$695K 0.1% 255
2020
Q2 		$53K Buy
+10,933
New +$50.3K 0.01% 997

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Virtu Financial's AQST Position: Q2 2026 in Review

Virtu Financial opened a new position in Aquestive Therapeutics (AQST) in Q2 2026: 69,576 shares worth $289K. The stake represents 0.01% of the portfolio and ranks #749 among its holdings. This is a return to the name: Virtu Financial previously reported a position in AQST as recently as Q3 2025.

Virtu Financial first reported a position in AQST in Q2 2020 and has held it in 15 quarters since. The position peaked at $661K in Q3 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Virtu Financial held 69,576 shares of Aquestive Therapeutics worth $289K as of Q2 2026.
  • Aquestive Therapeutics was a new Virtu Financial position in Q2 2026.
  • Aquestive Therapeutics made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #749 holding.
  • Virtu Financial first reported a position in Aquestive Therapeutics in Q2 2020 and has held it in 15 quarters since.
  • Virtu Financial's Aquestive Therapeutics position peaked at $661K in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.